N/A
N=31
An Evaluation of the Effect of the Erchonia Laser for Non-invasive Reduction of Submental Fat
Weight Loss
Bottom Line
View on ClinicalTrials.gov: NCT05954065 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Proportion of Accurately Identified Subject Pre- and Post-treatment Photographs by at Least Two of the Three Blinded Independent Evaluators. — 26 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Erchonia CFL Laser (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Erchonia Corporation
- Primary completion
- May 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Proportion of Accurately Identified Subject Pre- and Post-treatment Photographs by at Least Two of the Three Blinded Independent Evaluators. |
26 | — |
| SECONDARY Change in Submental Skinfold Thickness (mm) |
-2.71 | — |
Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® CFL (manufactured by Erchonia Corporation (the Company), in providing noninvasive fat reduction in the submental area.
Eligibility Criteria
Inclusion Criteria
- Male or female 18 to 65 years of age, inclusive.
- Submental and submandibular skin fold thickness > 1cm (measured by caliper).
- Subject agrees to maintain his/her weight (i.e., within 5%) by not making any major changes in diet or exercise routine during the course of the study.
- Subject agrees to abstain from partaking in any treatment to promote body contouring and/or weight loss during the course of study participation. Such treatments include, but are not limited to:
- over-the-counter and/or prescription medications; dietary/herbal supplements and appetite suppressants.
- weight loss programs/diet plans.
- surgical procedures for sculpting of the chin fat pad/weight loss, e.g. submental lipectomy, lap bands.
- Subject has signed a written informed consent form.
Exclusion Criteria
- Evidence of any cause of enlargement in the submental area other than localized subcutaneous fat, such as swollen lymph nodes or ptotic submandibular glands.
- Treatment with dermal fillers, radiofrequency or laser procedures, or chemical peels in the neck or chin area (below the mandible) within the past 6 months.
- Botulinum toxin or other aesthetic drug injections within the neck or chin area (below the mandible) within the past 6 months.
- History of a fat reduction procedure (e.g., liposuction, surgery, lipolytic agents, etc.) or implant in or adjacent to the area of intended treatment.
- Any dermatological conditions, such as scars in the location of the treatment area that may interfere with the treatment or evaluation.
- Active implanted device such as a pacemaker, defibrillator, or drug delivery system.
- Pregnant or intending to become pregnant in the next 6 months.
- Currently enrolled in a clinical study of an unapproved investigational drug or device.
Data sourced from ClinicalTrials.gov (NCT05954065). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.